BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38225170)

  • 1. VEXAS-Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort.
    Corty RW; Brogan J; Byram K; Springer J; Grayson PC; Bick AG
    Arthritis Rheumatol; 2024 Jun; 76(6):942-948. PubMed ID: 38225170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
    Ferrada MA; Savic S; Cardona DO; Collins JC; Alessi H; Gutierrez-Rodrigues F; Kumar DBU; Wilson L; Goodspeed W; Topilow JS; Paik JJ; Poulter JA; Kermani TA; Koster MJ; Warrington KJ; Cargo C; Tattersall RS; Duncan CJA; Cantor A; Hoffmann P; Payne EM; Bonnekoh H; Krause K; Cowen EW; Calvo KR; Patel BA; Ombrello AK; Kastner DL; Young NS; Werner A; Grayson PC; Beck DB
    Blood; 2022 Sep; 140(13):1496-1506. PubMed ID: 35793467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic
    Tsuchida N; Kunishita Y; Uchiyama Y; Kirino Y; Enaka M; Yamaguchi Y; Taguri M; Yamanaka S; Takase-Minegishi K; Yoshimi R; Fujii S; Nakajima H; Matsumoto N
    Ann Rheum Dis; 2021 Aug; 80(8):1057-1061. PubMed ID: 33789873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies.
    Sakuma M; Blombery P; Meggendorfer M; Haferlach C; Lindauer M; Martens UM; Kern W; Haferlach T; Walter W
    Leukemia; 2023 May; 37(5):1080-1091. PubMed ID: 36823397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.
    Stiburkova B; Pavelcova K; Belickova M; Magaziner SJ; Collins JC; Werner A; Beck DB; Balajkova V; Salek C; Vostry M; Mann H; Vencovsky J
    Arthritis Rheumatol; 2023 Jul; 75(7):1285-1290. PubMed ID: 36762418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic monitoring of UBA1 somatic mutations in patients with relapsing polychondritis.
    Duan S; Luo H; Wang Y; Jiang D; Liu J; Li J; Zheng H; Zhao T; Liu C; Zhang H; Mao C; Zhang L; Xu Y
    Orphanet J Rare Dis; 2024 Jan; 19(1):1. PubMed ID: 38167209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing can misread high variant allele fraction of somatic variants in UBA1 as hemizygous in VEXAS syndrome: a case report.
    Wilke MVMB; Morava-Kozicz E; Koster MJ; Schmitz CT; Foster SK; Patnaik M; Warrington KJ; Klee EW; Pinto E Vairo F
    BMC Rheumatol; 2022 Aug; 6(1):54. PubMed ID: 36038944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
    Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
    Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome.
    Ospina Cardona D; Rodriguez-Pinto I; Iosim S; Bonet N; Mensa-Vilaro A; Wong MK; Ho G; Tormo M; Yagüe J; Shon W; Wallace D; Casals F; Beck DB; Abuav R; Arostegui JI
    Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38552317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
    Zakine E; Schell B; Battistella M; Vignon-Pennamen MD; Chasset F; Mahévas T; Cordoliani F; Adès L; Sébert M; Delaleu J; Jachiet M; Lepelletier C; Lemaire P; Chauvel C; Dhouaieb B; Kim R; Cassius C; Georgin-Lavialle S; Mekinian A; Bagot M; Braun T; Rousset L; Begon E; de Masson A; Fenaux P; Clappier E; Bouaziz JD
    JAMA Dermatol; 2021 Nov; 157(11):1349-1354. PubMed ID: 34495287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic Mutations in
    Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
    N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome.
    Maeda A; Tsuchida N; Uchiyama Y; Horita N; Kobayashi S; Kishimoto M; Kobayashi D; Matsumoto H; Asano T; Migita K; Kato A; Mori I; Morita H; Matsubara A; Marumo Y; Ito Y; Machiyama T; Shirai T; Ishii T; Kishibe M; Yoshida Y; Hirata S; Akao S; Higuchi A; Rokutanda R; Nagahata K; Takahashi H; Katsuo K; Ohtani T; Fujiwara H; Nagano H; Hosokawa T; Ito T; Haji Y; Yamaguchi H; Hagino N; Shimizu T; Koga T; Kawakami A; Kageyama G; Kobayashi H; Aoki A; Mizokami A; Takeuchi Y; Motohashi R; Hagiyama H; Itagane M; Teruya H; Kato T; Miyoshi Y; Kise T; Yokogawa N; Ishida T; Umeda N; Isogai S; Naniwa T; Yamabe T; Uchino K; Kanasugi J; Takami A; Kondo Y; Furuhashi K; Saito K; Ohno S; Kishimoto D; Yamamoto M; Fujita Y; Fujieda Y; Araki S; Tsushima H; Misawa K; Katagiri A; Kobayashi T; Hashimoto K; Sone T; Hidaka Y; Ida H; Nishikomori R; Doi H; Fujimaki K; Akasaka K; Amano M; Matsushima H; Kashino K; Ohnishi H; Miwa Y; Takahashi N; Takase-Minegishi K; Yoshimi R; Kirino Y; Nakajima H; Matsumoto N
    Rheumatology (Oxford); 2023 Aug; ():. PubMed ID: 37606963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.
    Tan IJ; Ferrada MA; Ahmad S; Fike A; Quinn KA; Groarke EM; Beck DB; Allbritton J; Castelo-Soccio L; Young NS; Patel BA; Grayson PC; Cowen EW
    JAMA Dermatol; 2024 Jun; ():. PubMed ID: 38865133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic manifestations of VEXAS syndrome.
    Groarke EM; Dulau-Florea AE; Kanthi Y
    Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and genetic features of MDS associated with VEXAS syndrome].
    Kunimoto H
    Rinsho Ketsueki; 2024; 65(4):255-264. PubMed ID: 38684436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
    Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
    Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEXAS syndrome in dermatology.
    Afsahi V; Christensen RE; Alam M
    Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.